Complementary and alternative medicine use among cancer patients at the end of life

Korean national study

Jin Young Choi, Yoon Jung Chang, Young Seon Hong, Dae Seog Heo, Samyong Kim, Jung Lim Lee, Jong Soo Choi, Ki Mun Kang, Si Young Kim, Hyun Sik Jeong, Chang Geol Lee, Youn Seon Choi, Ho Yeong Lim, Young Ho Yun

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objectives: To investigate in depth the use of complementary and alternative medicines (CAMs) by cancer patients at the end-of-life (EOL) and how they communicate with physicians about them. Design and location: In 17 hospitals in Korea between January and December 2004 we identified 4,042 families of cancer patients. Results: The prevalence of CAM use among cancer patients at the EOL was 37.0%, and 93.1% had used pharmacologic types of agents. The most frequent motive for CAM use was the recommendation of friends or a close relative (53.4%) or a physician (1.6%). Only 42.5% discussed CAM use with their physicians. Satisfaction with CAMS was recalled for 37.1%. The most common reason given for that satisfaction was improvement of emotional or physical well-being, while ineffectiveness was the most common reason given for dissatisfaction. The average cost of CAM during the last month of life was $US 900. CAM use was associated with longer disease periods, primary cancers other than liver, biliary, and pancreatic, and need of support from physicians or religion. Conclusions: CAM use among cancer patients at the EOL was common, not discussed with physicians, and associated with expectation of cure. Expectations were generally unmet while the treatments were a financial burden. Further studies evaluating the effects of CAM at the EOL and factors that enhance communication with the physician are needed.

Original languageEnglish
Pages (from-to)1419-1424
Number of pages6
JournalAsian Pacific Journal of Cancer Prevention
Volume13
Issue number4
DOIs
Publication statusPublished - 2012 Jan 1

Fingerprint

Complementary Therapies
Neoplasms
Physicians
Religion
Liver Neoplasms
Korea

Keywords

  • Complementary and alternative medicine
  • End of life
  • Korean cancer patients

ASJC Scopus subject areas

  • Epidemiology
  • Oncology
  • Public Health, Environmental and Occupational Health
  • Cancer Research

Cite this

Complementary and alternative medicine use among cancer patients at the end of life : Korean national study. / Choi, Jin Young; Chang, Yoon Jung; Hong, Young Seon; Heo, Dae Seog; Kim, Samyong; Lee, Jung Lim; Choi, Jong Soo; Kang, Ki Mun; Kim, Si Young; Jeong, Hyun Sik; Lee, Chang Geol; Choi, Youn Seon; Lim, Ho Yeong; Yun, Young Ho.

In: Asian Pacific Journal of Cancer Prevention, Vol. 13, No. 4, 01.01.2012, p. 1419-1424.

Research output: Contribution to journalArticle

Choi, JY, Chang, YJ, Hong, YS, Heo, DS, Kim, S, Lee, JL, Choi, JS, Kang, KM, Kim, SY, Jeong, HS, Lee, CG, Choi, YS, Lim, HY & Yun, YH 2012, 'Complementary and alternative medicine use among cancer patients at the end of life: Korean national study', Asian Pacific Journal of Cancer Prevention, vol. 13, no. 4, pp. 1419-1424. https://doi.org/10.7314/APJCP.2012.13.4.1419
Choi, Jin Young ; Chang, Yoon Jung ; Hong, Young Seon ; Heo, Dae Seog ; Kim, Samyong ; Lee, Jung Lim ; Choi, Jong Soo ; Kang, Ki Mun ; Kim, Si Young ; Jeong, Hyun Sik ; Lee, Chang Geol ; Choi, Youn Seon ; Lim, Ho Yeong ; Yun, Young Ho. / Complementary and alternative medicine use among cancer patients at the end of life : Korean national study. In: Asian Pacific Journal of Cancer Prevention. 2012 ; Vol. 13, No. 4. pp. 1419-1424.
@article{08e91e33564440148b90630432bdfbf2,
title = "Complementary and alternative medicine use among cancer patients at the end of life: Korean national study",
abstract = "Objectives: To investigate in depth the use of complementary and alternative medicines (CAMs) by cancer patients at the end-of-life (EOL) and how they communicate with physicians about them. Design and location: In 17 hospitals in Korea between January and December 2004 we identified 4,042 families of cancer patients. Results: The prevalence of CAM use among cancer patients at the EOL was 37.0{\%}, and 93.1{\%} had used pharmacologic types of agents. The most frequent motive for CAM use was the recommendation of friends or a close relative (53.4{\%}) or a physician (1.6{\%}). Only 42.5{\%} discussed CAM use with their physicians. Satisfaction with CAMS was recalled for 37.1{\%}. The most common reason given for that satisfaction was improvement of emotional or physical well-being, while ineffectiveness was the most common reason given for dissatisfaction. The average cost of CAM during the last month of life was $US 900. CAM use was associated with longer disease periods, primary cancers other than liver, biliary, and pancreatic, and need of support from physicians or religion. Conclusions: CAM use among cancer patients at the EOL was common, not discussed with physicians, and associated with expectation of cure. Expectations were generally unmet while the treatments were a financial burden. Further studies evaluating the effects of CAM at the EOL and factors that enhance communication with the physician are needed.",
keywords = "Complementary and alternative medicine, End of life, Korean cancer patients",
author = "Choi, {Jin Young} and Chang, {Yoon Jung} and Hong, {Young Seon} and Heo, {Dae Seog} and Samyong Kim and Lee, {Jung Lim} and Choi, {Jong Soo} and Kang, {Ki Mun} and Kim, {Si Young} and Jeong, {Hyun Sik} and Lee, {Chang Geol} and Choi, {Youn Seon} and Lim, {Ho Yeong} and Yun, {Young Ho}",
year = "2012",
month = "1",
day = "1",
doi = "10.7314/APJCP.2012.13.4.1419",
language = "English",
volume = "13",
pages = "1419--1424",
journal = "Asian Pacific Journal of Cancer Prevention",
issn = "1513-7368",
publisher = "Asian Pacific Organization for Cancer Prevention",
number = "4",

}

TY - JOUR

T1 - Complementary and alternative medicine use among cancer patients at the end of life

T2 - Korean national study

AU - Choi, Jin Young

AU - Chang, Yoon Jung

AU - Hong, Young Seon

AU - Heo, Dae Seog

AU - Kim, Samyong

AU - Lee, Jung Lim

AU - Choi, Jong Soo

AU - Kang, Ki Mun

AU - Kim, Si Young

AU - Jeong, Hyun Sik

AU - Lee, Chang Geol

AU - Choi, Youn Seon

AU - Lim, Ho Yeong

AU - Yun, Young Ho

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Objectives: To investigate in depth the use of complementary and alternative medicines (CAMs) by cancer patients at the end-of-life (EOL) and how they communicate with physicians about them. Design and location: In 17 hospitals in Korea between January and December 2004 we identified 4,042 families of cancer patients. Results: The prevalence of CAM use among cancer patients at the EOL was 37.0%, and 93.1% had used pharmacologic types of agents. The most frequent motive for CAM use was the recommendation of friends or a close relative (53.4%) or a physician (1.6%). Only 42.5% discussed CAM use with their physicians. Satisfaction with CAMS was recalled for 37.1%. The most common reason given for that satisfaction was improvement of emotional or physical well-being, while ineffectiveness was the most common reason given for dissatisfaction. The average cost of CAM during the last month of life was $US 900. CAM use was associated with longer disease periods, primary cancers other than liver, biliary, and pancreatic, and need of support from physicians or religion. Conclusions: CAM use among cancer patients at the EOL was common, not discussed with physicians, and associated with expectation of cure. Expectations were generally unmet while the treatments were a financial burden. Further studies evaluating the effects of CAM at the EOL and factors that enhance communication with the physician are needed.

AB - Objectives: To investigate in depth the use of complementary and alternative medicines (CAMs) by cancer patients at the end-of-life (EOL) and how they communicate with physicians about them. Design and location: In 17 hospitals in Korea between January and December 2004 we identified 4,042 families of cancer patients. Results: The prevalence of CAM use among cancer patients at the EOL was 37.0%, and 93.1% had used pharmacologic types of agents. The most frequent motive for CAM use was the recommendation of friends or a close relative (53.4%) or a physician (1.6%). Only 42.5% discussed CAM use with their physicians. Satisfaction with CAMS was recalled for 37.1%. The most common reason given for that satisfaction was improvement of emotional or physical well-being, while ineffectiveness was the most common reason given for dissatisfaction. The average cost of CAM during the last month of life was $US 900. CAM use was associated with longer disease periods, primary cancers other than liver, biliary, and pancreatic, and need of support from physicians or religion. Conclusions: CAM use among cancer patients at the EOL was common, not discussed with physicians, and associated with expectation of cure. Expectations were generally unmet while the treatments were a financial burden. Further studies evaluating the effects of CAM at the EOL and factors that enhance communication with the physician are needed.

KW - Complementary and alternative medicine

KW - End of life

KW - Korean cancer patients

UR - http://www.scopus.com/inward/record.url?scp=84873054442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873054442&partnerID=8YFLogxK

U2 - 10.7314/APJCP.2012.13.4.1419

DO - 10.7314/APJCP.2012.13.4.1419

M3 - Article

VL - 13

SP - 1419

EP - 1424

JO - Asian Pacific Journal of Cancer Prevention

JF - Asian Pacific Journal of Cancer Prevention

SN - 1513-7368

IS - 4

ER -